ThursdayJun 25, 2020 10:00 am

Psychedelics Could Treat Physical Health Conditions

There is a general consensus in the research community that psychedelics have immense potential in the treatment of mental health conditions. As more scientists have picked interest in these substances, it is also becoming apparent that the therapeutic role of psychedelics could extend to treating physical health conditions that aren’t connected to one’s mental state. One big area where psychedelics could have numerous applications is in managing the inflammatory pathways responsible for several conditions afflicting humans. These disorders include those affecting the lungs, heart and the eyes. This exciting research is also focusing on the serotonin receptors, just as the…

Continue Reading

WednesdayJun 24, 2020 3:00 pm

Take Your Pick: Synthetic Psilocybin or Magic Mushroom Pills?

Decades ago, psychedelics like “magic mushrooms” were viewed as the preserve of the counterculture crowd who would be spotted chomping away on woody stems and dry caps. Today, a new picture of laboratory-produced synthetic psilocybin pills is emerging and it could soon send the consumption mode of yesteryears into oblivion. How did we get here? In 1963, Albert Hoffman, the Swiss scientist who synthesized LSD, received a small package containing 100 grams of magic mushrooms. This package was a gift from Maria Sabina, a Mazateca healer who hailed from Southern Mexico. Hoffman immediately went to work in his lab, and…

Continue Reading

WednesdayJun 24, 2020 10:00 am

Mental Health Startup Aims to Help Patients Access Psychedelic Treatment

As the medical and scientific community embrace psychedelic treatment, and as regulators clear these treatments, a need has arisen to take prospective patients through the entire process so that they make informed decisions and know who to turn to for help. Osmind, a mental health startup, has risen to the occasion to provide the needed support. Osmind aims at creating a community for people seeking psychedelic treatments which have FDA-approval. Currently, only ketamine has this regulatory approval, but industry insiders expect similar approval to be given to psilocybin and MDMA. Osmind is building an app as well as an online…

Continue Reading

TuesdayJun 23, 2020 2:00 pm

A Look at the Potential of Psychedelics in Treating Bipolar Disorder

For decades, the general agreement within scientific circles has been that people with bipolar disorder should stay away from psychedelics as these substances could worsen their condition. The reasoning behind this recommendation has always been that psychedelics can trigger manic episodes in people with bipolar disorder, and that was too huge a risk to take. This concern isn’t a myth as there are recorded cases of people going into a manic episode. Psychedelics tend to impact the serotonin system within the brain, and for people with bipolar, this could trigger mania or “mood episodes.” In fact, researchers say that the…

Continue Reading

TuesdayJun 23, 2020 9:30 am

Support for Legalizing Psychedelics is on Same Trajectory Marijuana Took

Just as was the case for marijuana, public support for the legalization of psychedelic substances like psilocybin is growing steadily across the U.S. According to Green Horizons, a research firm, approximately 38% of all adults in the country believe “magic mushrooms” should be legal. The same report goes on to reveal that 25% believe that psilocybin should be legal but under controlled circumstances. Adriana Waterston, the Senior Vice President in charge of Insights and Strategy at Green Horizons, said in a press release that there are striking parallels between the push to legalize marijuana and what is being seen in…

Continue Reading

MondayJun 22, 2020 3:00 pm

What is Psychedelic Integration?

There is no doubt that psychedelics are valuable tools for self-understanding, healing and transformation. They help an individual to peer into their inner workings and consequently, develop and see the world in different ways. The changes and insights that a person gains during a psychedelic experience are disruptive to their normal way of looking at things, and that is why some work has to be done to accommodate those changes which are likely to be triggered. This necessary work is called “psychedelic integration.” Psychedelic integration starts with being committed to use your psychedelic experience as a basis for changing your…

Continue Reading

MondayJun 22, 2020 9:00 am

Australia Considers Using Psychedelics to Treat Mental Disorders Among Veterans

The Australian Department of Veterans Affairs (“DVA”) is considering a request to grant Defense Force veterans access to psychedelic drugs like psilocybin and MDMA to treat a host of mental disorders like depression, PTSD, anxiety and addiction. 42-year old Joel Harrop is one such veteran who turned to psychedelics after conventional medications couldn’t ease his anxiety, manic depressive disorder and PTSD brought on during his service in the armed forces. When Harrop started psychedelic therapy, he was once again able to leave the house, meet friends and start leading a relatively normal life after being unable to leave his home…

Continue Reading

FridayJun 19, 2020 3:45 pm

Protests Give DC Psychedelics Decriminalization Signature Gathering a Boost

The ongoing “Black Lives Matter” protests which have engulfed the country have given a local campaign effort in Washington D.C. a needed boost as they have been able to gather 5,000 signatures for their cause of putting psychedelics decriminalization on the November ballot. Decriminalize Nature D.C. (“DNDC”) is the organization behind the campaign to decriminalize entheogenic substances, such as psilocybin and ibogaine, so that they drop down the list of law enforcement priorities in D.C. The activists have to collect approximately 30,000 valid signatures of voters by July 6 if their plan to put the matter on the November ballot…

Continue Reading

FridayJun 19, 2020 4:20 am

Company Seeks FDA Approval to Conduct US Human LSD Trials

Mind Medicine (NEO: MMED) (OTCQB: MMEDF), a psychedelic pharmaceutical company, has approached the U.S. Food and Drug Administration (“FDA”) for authorization to conduct a clinical trial on LSD as a treatment of anxiety. Interestingly, the MindMed project is called “Project Lucy.” For those who may not know, LSD is short for Lysergic Acid Diethylamide and The Beatles popularized this psychedelic drug by asking people to search for “Lucy in the Sky with Diamonds,” a thinly veiled reference to LSD. It is therefore no wonder that MindMed called their work in this area “Project Lucy.” This isn’t the first time that…

Continue Reading

ThursdayJun 18, 2020 4:20 pm

Celebrities Recount Their Psychedelic Trips in New Netflix Documentary

A new Netflix documentary called “Have a Good Trip: Adventures in Psychedelics” premiered on Netflix on May 11 this year and it is generating quite a buzz because of the topic it explores. In this documentary, several stars share their experiences of taking psychedelic drugs. Actors reenact those experiences being described by the celebrities, and experts delve into the science of why and what psychedelics can offer the medical community. The lineup of celebrities who feature in the documentary is quite impressive. They include Ben Stiller, Sarah Silverman, and Natasha Lyonne. Even stars who have passed on, such as Carrie…

Continue Reading

PsychedelicNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000